Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

EAU's new guidelines recommend Sutent in first-line metastatic RCC

March 27, 2007

Genta expects negative European opinion for Genasense in advanced melanoma

March 27, 2007

Affirmative preclinical profile set BEZ-235 for clinical evaluation

March 27, 2007

Dll4 as a novel target for antiangiogenic drugs

March 27, 2007

Clomet studied in phase I for solid tumors

March 26, 2007

ASKA and Yakult Honsha sign agreement for soblidotin

March 26, 2007

IL-21 benefits mice with melanoma

March 26, 2007

Phase I/II studies to investigate nab-docetaxel for prostate and breast cancers

March 26, 2007

Terameprocol found effective in patients with oral leukoplakia

March 26, 2007

HEP27: a novel target for selective VTAs

March 23, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...